Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

查看全文 作　　者：Jing-Ming [1]Ye;Bao-Liang [2]Guo;Qian [1]Liu;Fei [2]Ma;Hong-Jin [1]Liu;Qian [1]Wu;Ling [1]Xin;Yuan-Jia [1]Cheng;Hong [3]Zhang;Shuang [3]Zhang;Xue-Ning [1]Duan;Jian-Guo [2]Zhang;Yin-Hua [1]Liu

机构地区：[1]Breast Disease Center,Peking University First Hospital,Beijing 100034,China;[2]Department of General Surgery,The Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang 150001,China;[3]Department of Pathology,Peking University First Hospital,Beijing 100034,China.

出　　处：《Chinese Medical Journal》索引2021年第8期,共9页

摘　　要：Axillary lymph node assessment is one of the important indicators in the clinical pathological staging of breast cancer.Studies have shown that sentinel lymph node biopsy(SLNB)has the advantages of fewer complications and less trauma than conventional axillary lymph node dissection(ALND)/[1] Common mapping methods for SLNB include blue dye,radioisotopes,a combination of blue dye and radioisotopes,and fluorescence imaging. 关键词：SURGERY LYMPH BIOPSY

相关文献

参考文献（75）
引证文献（31）
耦合文献（116）

参考文献(75)

引证文献(31)

耦合文献(116)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

参考文献(75)

引证文献(31)

耦合文献(116)

用户提示